Image

Response Profiles to High-concentration Capsaicin Desensitization in Patients With Peripheral Neuropathic Pain With or Without Allodynia: a Regional Multicenter Prospective Cohort

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

Prospective multicenter cohort to determine patient profiles (associated factors, including allodynia) with a better response to pain desensitization by capsaicin delivered in the form of a high concentration patch (8%), in a population of patients with peripheral neuropathic pain and followed up in a pain consultation in the Auvergne Rhône Alpes region.

Eligibility

Inclusion Criteria:

  • Patient over 18 years of age on the day of inclusion
  • Patient who has been informed and has not expressed opposition to participating in the study,
  • Patient with peripheral neuropathic pain (whatever the etiology), defined by :
    • "Neuropathic Pain 4" score ("DN4" score) ≥ 4/10
    • AND pain according to the numerical scale (EN) > 4/10,
    • AND stable analgesic treatment for at least 1 month,
    • AND with or without mechanical allodynia according to the Quantitative Sensory Testing (QST) : Brush test (dynamic), Von Frey test (static)
    • AND with or without thermal allodynia to hot or cold as determined by a ROLLTEMP-II® (Rolltemp is a device designed for quick screening of temperature sensibility over large body areas).
  • Patient responding to an indication of desensitization to high concentration capsaicin

    concentration and not presenting any contra-indication.

  • Patient naïve of high concentration of Capsaicin on the concerned zone
  • Patient understanding French

Non-inclusion Criteria:

  • Patient with pain related to complex regional pain syndrome (criteria not meeting the indication for capsaicin)
  • Patient with active cancer (underlying disease and treatments may modify pain perception),
  • Patient receiving or having received in the last 3 months Botulinum toxin A on the concerned area (this treatment of neuropathic pain may modulate the effect of capsaicin and disturb the demonstration of causality),
  • Patient with planned surgery within the next 12 months on the painful site (surgery may cause neuropathic damage and/or bias the pain assessment),
  • Patient included in an interventional research protocol,
  • Patient under guardianship or curators,
  • Patient under legal protection

Exclusion Criteria:

None

Study details

Peripheral Neuropathic Pain

NCT05817591

Centre Hospitalier Annecy Genevois

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.